Sustained HPV-16 and 18 Antibody Levels Through 5.5 Years in Women Vaccinated with the HPV-16/18 L1 VLP AS04 Candidate Vaccine by Diane M. Harper given during the 15th International Meeting of the European Society of Gynaecological Oncology (ESGO) powered by - MULTIWEBCAST

15th International Meeting of the European Society of Gynaecological Oncology (ESGO)

LIST OF PRESENTATIONS/COURSES

OTHER WEBCASTS

Webcasted Presentation

BROWSE:

ALL PRESENTATIONS/COURSES

SPEAKERS

PPT SLIDES

VIDEO PODCASTS

Sustained HPV-16 and 18 Antibody Levels Through 5.5 Years in Women Vaccinated with the HPV-16/18 L1 VLP AS04 Candidate Vaccine

Diane M. Harper

United States of America

Disclosure : - Research support from Sanofi Pasteur/Aventis and GSK
- Consultant Sanofi Pasteur/Aventis and GSK, specifically for the HPV Vaccines Trials

[More] [Less]

PRESENTATION

17 slide(s) – 00:05:57 – English – 2007-10-31

Extra Features Available

VIDEO PODCAST

SLIDE LIBRARY

Rate & Comment

A A A


Rate:
Please let us know how useful this content was for you and feel free to write your comments below.

Disclaimer ^{AMENDED ON January 29, 2009} | Technical Support

USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.

Search’n Build™